PHARMANUTRA S.P.A. earnings
Annual earnings per share (EUR per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €2090.00 | — | 2026-06-19T06:43:20Z |
| 2024 | 2024-12-31 | €1730.00 | — | 2026-06-19T06:43:20Z |
Revenue & profit (EUR)
| Concept | 2025 | 2024 |
|---|---|---|
| Revenue | €131.7M | €115.5M |
| Profit for the year | €20.0M | €16.6M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in PHARMANUTRA S.P.A.'s ESEF annual reports (source:
filings.xbrl.org).
Figures are in EUR, as reported. Not investment advice.